SPECIAL INTEREST GROUP (SIG) MEETINGS
Sunday, 1 to 2:30 p.m.
- Retinal microglia in degenerative diseases: Why function matters
- A Matter of Life or Death: Regulation of RGC Survival by Glia and Interneurons
- Update on clinical gene therapy trials for inherited retinal diseases
- Extracellular Vesicles and the Anterior Segment
- Toward Guidelines for Mouse Electroretinography
- Biomarkers and Surrogate Endpoints in Ophthalmic Clinical Research
- Delivery of therapeutics to ocular tissues
Monday, 1:30 to 3 p.m.
- Telemedicine and Artificial Intelligence using Deep Learning Systems to Screen and Monitor Diabetic Retinopathy, Glaucoma and Age-related Macular Degeneration using Different Imaging Modalities
- Phagocytic mechanisms in ocular tissues: from physiological to pathological processes
- Omega-3 Fatty Acid Supplementation for Dry Eye Disease: Data on Efficacy and Safety from the Dry Eye Assessment and Management (DREAM©) Study
- Managing Patients with Diabetic Macular Edema, Diabetic Retinopathy, Neovascular and Non-Neovascular AMD, and Retinal Vein Occlusion: How to Best Utilize the Latest Data from Clinical Trials
- Eye and Brain - the interrelationship and pathology
- Membrane dynamics in RPE health and disease
- The Lasker/IRRF Initiative for Innovation in Vision Science: Glaucoma and Diabetic Retinopathy
Tuesday, 1:30 to 3 p.m.
- Objective Quantification of Intraocular Inflammation: Using Newer Technologies to Overcome an Old Challenge
- Next-Gen Autofluorescence Imaging – Let’s Get Ready
- Immune tolerance in steady state and ocular surface/corneal diseases
- Molecular Imaging of the Retina in Health and Disease
- Optical Coherence Tomography Angiography of the Eye
- Gene therapy of glaucoma
- Lipid and Lipid Targeted Therapies for Eye Diseases- past, present and future
- The Lasker/IRRF Initiative for Innovation in Vision Science: Restoring Vision to the Blind and Amblyopia
Wednesday, 1:30 to 3 p.m.
- Animal Models of Ocular Trauma
- Biobanking with a Purpose: Advancing Research in Ophthalmology
- Regenerative Medicine Wnt Signaling and Retinal Vascular Disease
- Optical Coherence Tomography and Ophthalmic Surgery: New Visualizations, Functional Analysis, and Enabling Robotic Assistance
- Patient report outcome measures (PROMs) in clinical glaucoma research: refining current tools, exploring new opportunities and improving means of data capture and analysis
- Ontology and Common Data Elements for Collaborative Research in Ophthalmology
- Phagocytosis in the outflow pathway: what we can learn from other ocular tissues
- Mechanisms and therapies for corneal endothelial dysfunction
Pre-Meeting Education Courses
Several courses will be held on Saturday before ARVO officially kicks off. Separate registration is required for each.
Big Data: Principles to Practical Application, 8 a.m. to 4:30 p.m.
“Big Data” is a big buzzword in healthcare today. The use of Big Data for improving healthcare outcomes and controlling costs shows significant promise. This course will help participants define what Big Data is, describe the Big Data sets available in vision research, explain the analytic methods behind Big Data, and summarize the potential applications of Big Data.
Gene Editing with CRISPR: From discovery to therapy, 8 a.m. to 4:30 p.m.
In the current era of personalized medicine, a large number of genetic variants in patients with various diseases using next generation sequencing have been identified. Recent advances in genetic engineering, genotyping, high-resolution imaging and biomarker testing have made it easier to deliver the right treatments to the right patients at the right time. This course presents an overview of CRISPR technology from the leading experts who have pioneered it in other disciplines, followed by examples in eye and vision science and practical applications.
Inherited Retinal Diseases: Divergent Viewpoints of Pathogenesis and Treatment, 8 a.m. to 4:30 p.m.
Inherited retinal diseases are a group of eye disorders caused by an inherited gene mutation and can cause vision loss or blindness. The primary goal of this course is to discuss opposing viewpoints related to the various treatment strategies for inherited retinal diseases. Further, learners will be able to identify and debate different clinical and research topics in the area of inherited retinal diseases. Perspectives on the use of stem cells and gene-directed therapy will be emphasized. In addition, the primary mechanism of retinal degeneration in patients with Stargardt disease will be discussed.
Introduction to AMD: Current research and therapeutics, 8 a.m. to 12:30 p.m.
This course will examine key clinical and pathological findings in AMD. Genetic insights will be highlighted, including the discovery of key biochemical pathways. Potential new therapies that could interrupt these pathways also will be explored.
Mark Your Calendar
Future ARVO Meetings
2019: April 28-May 2 â Vancouver
2020: May 3-7 â Baltimore
2021: May 2-6 â San Francisco
2022: May 1-5 â Denver